Dual targeting of EGFR: ready for prime time?
- Author(s)
- Gan, Hui K; Burgess, Antony W; Parslow, Adam C; Scott, Andrew M;
- Details
- Publication Year 2016,Volume 5,Issue #Suppl 1,Page S18-S21
- Journal Title
- Translational Cancer Research
- Publication Type
- Journal Article
- Abstract
- Monoclonal antibodies against the Epidermal Growth Factor Receptor (EGFR) are accepted therapies in number of cancer types including colorectal cancer (CRC), and head and neck cancer.
- Publisher
- AME Publishing Company
- Research Division(s)
- Structural Biology
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2017-05-26 03:48:49
Last Modified: 2020-04-07 02:34:58